GR870930B - Ligands and methods for augmenting b- cell proliferation - Google Patents

Ligands and methods for augmenting b- cell proliferation

Info

Publication number
GR870930B
GR870930B GR870930A GR870100930A GR870930B GR 870930 B GR870930 B GR 870930B GR 870930 A GR870930 A GR 870930A GR 870100930 A GR870100930 A GR 870100930A GR 870930 B GR870930 B GR 870930B
Authority
GR
Greece
Prior art keywords
augmenting
ligands
methods
cell proliferation
proliferation
Prior art date
Application number
GR870930A
Other languages
Greek (el)
English (en)
Inventor
Ledbetter A Jeffrey
Edward A Clark
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of GR870930B publication Critical patent/GR870930B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR870930A 1986-06-13 1987-06-15 Ligands and methods for augmenting b- cell proliferation GR870930B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87388486A 1986-06-13 1986-06-13

Publications (1)

Publication Number Publication Date
GR870930B true GR870930B (en) 1987-12-16

Family

ID=25362524

Family Applications (1)

Application Number Title Priority Date Filing Date
GR870930A GR870930B (en) 1986-06-13 1987-06-15 Ligands and methods for augmenting b- cell proliferation

Country Status (22)

Country Link
JP (1) JPH0762040B2 (de)
KR (1) KR910004100B1 (de)
AT (1) AT398437B (de)
AU (1) AU617087B2 (de)
BE (1) BE1000587A4 (de)
CA (1) CA1338781C (de)
CH (1) CH676600A5 (de)
CY (1) CY1681A (de)
DE (1) DE3719398C2 (de)
DK (1) DK173940B1 (de)
FR (1) FR2607136B1 (de)
GB (1) GB2191494B (de)
GR (1) GR870930B (de)
HK (1) HK10293A (de)
IE (1) IE60486B1 (de)
IL (1) IL82841A (de)
IT (1) IT1208649B (de)
LU (1) LU86919A1 (de)
NL (1) NL195022C (de)
PT (1) PT85073B (de)
SE (1) SE504675C2 (de)
SG (1) SG118992G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
CO4600681A1 (es) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0117705A3 (de) * 1983-02-24 1985-09-25 The Regents Of The University Of California Monocyten und Blastzellen spezifischer monoklonaler Antikörper
FR2547731A1 (fr) * 1983-06-27 1984-12-28 Centre Nat Rech Scient Immunotoxine antitumorale, preparations pharmaceutiques la contenant et son utilisation in vitro
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof

Also Published As

Publication number Publication date
IE60486B1 (en) 1994-07-27
FR2607136A1 (fr) 1988-05-27
AU7421487A (en) 1987-12-17
IL82841A0 (en) 1987-12-20
DK302287A (da) 1987-12-14
CY1681A (en) 1993-10-10
DK302287D0 (da) 1987-06-12
IE871563L (en) 1987-12-13
DE3719398A1 (de) 1988-01-28
SE504675C2 (sv) 1997-04-07
DE3719398C2 (de) 1996-03-28
KR880000582A (ko) 1988-03-28
CA1338781C (en) 1996-12-10
LU86919A1 (fr) 1989-03-08
NL8701371A (nl) 1988-01-04
ATA151387A (de) 1994-04-15
BE1000587A4 (fr) 1989-02-14
GB2191494B (en) 1990-08-22
FR2607136B1 (fr) 1989-09-15
IT1208649B (it) 1989-07-10
SE8702463L (sv) 1987-12-14
IL82841A (en) 1992-11-15
SG118992G (en) 1993-01-29
AU617087B2 (en) 1991-11-21
CH676600A5 (de) 1991-02-15
JPS6480299A (en) 1989-03-27
SE8702463D0 (sv) 1987-06-12
JPH0762040B2 (ja) 1995-07-05
DK173940B1 (da) 2002-03-04
PT85073B (pt) 1990-07-31
KR910004100B1 (ko) 1991-06-22
GB8713650D0 (en) 1987-07-15
AT398437B (de) 1994-12-27
GB2191494A (en) 1987-12-16
PT85073A (en) 1987-07-01
HK10293A (en) 1993-02-19
NL195022C (nl) 2003-06-18
IT8720899A0 (it) 1987-06-12

Similar Documents

Publication Publication Date Title
GB2185840B (en) Cooking apparatus
YU198087A (en) Process for obtaining nor-statine and nor-cyclostatine
GB2224638B (en) Cooking apparatus
EP0273495A3 (en) Depilating apparatus
GB8629468D0 (en) Combustion apparatus
GB8615634D0 (en) Combustion apparatus
ZA872781B (en) B-cell stimulating factor
GB8617773D0 (en) Cooking apparatus
GB2186512B (en) Sharpening apparatus
ZA837200B (en) Hydrodewaxing catalyst and process
GB2218328B (en) Cooking apparatus
GB8622881D0 (en) Timing apparatus
IL88321A0 (en) Sialocylglycerolipids and method for preparing same
GB2191494B (en) Ligands and methods for augmenting b-cell proliferation
GB8602429D0 (en) Identifiction apparatus
GB8606027D0 (en) Induction apparatus
GB8723491D0 (en) Back support apparatus
GB8714195D0 (en) Food franfer method
GB8300949D0 (en) Kitchen exhaust apparatus
GB8608146D0 (en) Food dressing
GB2222936B (en) Cooking apparatus
GB8620015D0 (en) Combustion apparatus
ZA874175B (en) Cooking apparatus
ZA87608B (en) Cooking apparatus
GB8625275D0 (en) Cooking apparatus